Pacific Biosciences
PACB
#8182
Rank
HK$2.80 B
Marketcap
HK$9.02
Share price
-2.95%
Change (1 day)
-8.78%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of March 2026 : HK$2.16 Billion

According to Pacific Biosciences 's latest financial reports the company has HK$2.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$2.17 B-28.16%
2024-12-31HK$3.02 B-38.61%
2023-12-31HK$4.93 B-18.28%
2022-12-31HK$6.03 B-25.9%
2021-12-31HK$8.14 B229.51%
2020-12-31HK$2.47 B546.33%
2019-12-31HK$0.38 B-52.29%
2018-12-31HK$0.80 B63.17%
2017-12-31HK$0.49 B-11.99%
2016-12-31HK$0.55 B-12.47%
2015-12-31HK$0.63 B-18.88%
2014-12-31HK$0.78 B-9.91%
2013-12-31HK$0.87 B11.92%
2012-12-31HK$0.77 B-43.43%
2011-12-31HK$1.37 B-37.57%
2010-12-31HK$2.20 B207.02%
2009-12-31HK$0.71 B-12.26%
2008-12-31HK$0.81 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
HK$25.54 B 1,079.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$73.31 B 3,286.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.06 B 318.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$19.30 B 791.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
HK$0.76 B-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA